Industry: Healthcare
Czech Republic has limited success in challenge to plasma award
A UK court has upheld one of the Czech Republic’s grounds of challenge to a US$730 million treaty award won by investors in a blood plasma business, while dismissing or reserving judgment on other objections.
08 March 2024
Maldives wins award over covid-19 ventilators
The Maldives has reportedly prevailed in an arbitration against a Dubai-based trading group over its failure to deliver ventilators during the covid-19 pandemic.
26 February 2024
Novavax pays to settle covid-19 vaccine dispute
US biotech company Novavax has agreed to pay US$400 million to settle an ICC claim brought by global health organisation Gavi over a cancelled contract to supply covid-19 vaccines to low and middle-income countries.
22 February 2024
Janssen defeats bid to revive drug royalty claim
An appeal arbitrator has upheld an award that dismissed a US$405 million claim brought by a Danish biotech company against Belgium’s Janssen Pharmaceuticals over a blood cancer treatment.
23 January 2024
Japanese drugmaker wins fees in cancer drug feud
Japan’s Daiichi Sankyo says it has been awarded almost US$46 million in fees and costs after prevailing in an ICDR arbitration with US biotech group Seagen over rights to technology used in cancer medicines.
08 December 2023
Market manipulation scheme leads to set-aside in Hong Kong
A Hong Kong court has upheld a jurisdictional challenge to an HKIAC award in favour of the daughter of a jailed Chinese pharmaceuticals executive – relying on new evidence that emerged through criminal proceedings over a market manipulation scheme.
31 August 2023
Indian arbitrator refuses to restrain sale of hospital network
An Indian arbitrator has refused a Mumbai healthcare provider’s request for interim measures to restrain a US private equity firm from selling a hospital network to rival bidders.
18 August 2023
US biotech company seeks damages over troubled drug trial
A US biotech company is seeking over US$100 million in an AAA claim against a clinical research company for breaching a contract to run trials for an experimental antibody treatment – as both parties’ former CEOs are investigated for allegedly defrauding investors over the drug’s potential.
12 July 2023
Indian arbitrator to hear hospital takeover dispute
A Mumbai healthcare provider is pursuing arbitration against the private equity owners of a hospital network, accusing them of breaching an exclusivity agreement by accepting a rival offer to acquire the business.
05 May 2023
Irish biopharma company reports win against Janssen
A Dublin-based biopharma company says it has won an award against a subsidiary of Janssen Pharmaceuticals over licensing of nanotechnology used to treat schizophrenia and HIV – entitling it to back royalties of US$194 million and further royalties for more than a decade.
26 April 2023